Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s diseaseProceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (50), p.32145-32154 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Dec 15, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2009680117 ;PMID: 33257576Full text available |
|
2 |
Material Type: Article
|
Tau-targeting therapies for Alzheimer diseaseNature reviews. Neurology, 2018-07, Vol.14 (7), p.399-415 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2018 ;ISSN: 1759-4758 ;EISSN: 1759-4766 ;DOI: 10.1038/s41582-018-0013-z ;PMID: 29895964Full text available |
|
3 |
Material Type: Article
|
Comprehensive Review on Alzheimer's Disease: Causes and TreatmentMolecules (Basel, Switzerland), 2020-12, Vol.25 (24), p.5789 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules25245789 ;PMID: 33302541Full text available |
|
4 |
Material Type: Article
|
β-Amyloid accumulation in the human brain after one night of sleep deprivationProceedings of the National Academy of Sciences - PNAS, 2018-04, Vol.115 (17), p.4483-4488 [Peer Reviewed Journal]Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright © 2018 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Apr 24, 2018 ;Copyright © 2018 the Author(s). Published by PNAS. 2018 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1721694115 ;PMID: 29632177Full text available |
|
5 |
Material Type: Article
|
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseNature Medicine, 2021-07, Vol.27 (7), p.1187-1196 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-021-01369-8 ;PMID: 34155411Full text available |
|
6 |
Material Type: Article
|
High performance plasma amyloid-β biomarkers for Alzheimer's diseaseNature (London), 2018-02, Vol.554 (7691), p.249-254 [Peer Reviewed Journal]Copyright Nature Publishing Group Feb 8, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature25456 ;PMID: 29420472Full text available |
|
7 |
Material Type: Article
|
Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s diseaseProceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (42), p.E6535-E6544 [Peer Reviewed Journal]Volumes 1–89 and 106–113, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Oct 18, 2016 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1611073113 ;PMID: 27702899Full text available |
|
8 |
Material Type: Article
|
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's modelsNature medicine, 2019-01, Vol.25 (1), p.165-175 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2019 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0275-4 ;PMID: 30617325Full text available |
|
9 |
Material Type: Article
|
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyLancet neurology, 2021-09, Vol.20 (9), p.739-752 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;ISSN: 1474-4465 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(21)00214-3 ;PMID: 34418401Full text available |
|
10 |
Material Type: Article
|
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluidsJournal of neurochemistry, 2021-10, Vol.159 (2), p.211-233 [Peer Reviewed Journal]2021 International Society for Neurochemistry ;2021 International Society for Neurochemistry. ;Copyright © 2021 International Society for Neurochemistry ;ISSN: 0022-3042 ;EISSN: 1471-4159 ;DOI: 10.1111/jnc.15465 ;PMID: 34244999Full text available |
|
11 |
Material Type: Article
|
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisMolecular neurodegeneration, 2021-05, Vol.16 (1), p.30-12, Article 30 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1750-1326 ;EISSN: 1750-1326 ;DOI: 10.1186/s13024-021-00451-6 ;PMID: 33933117Full text available |
|
12 |
Material Type: Article
|
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNature Medicine, 2020-03, Vol.26 (3), p.398-407 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;2020© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-020-0781-z ;PMID: 32161412Full text available |
|
13 |
Material Type: Article
|
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseThe New England journal of medicine, 2014-01, Vol.370 (4), p.322-333 [Peer Reviewed Journal]Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;2014 Massachusetts Medical Society. 2014 ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1304839 ;PMID: 24450891 ;CODEN: NEJMAGFull text available |
|
14 |
Material Type: Article
|
Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s DiseaseMolecular neurobiology, 2018-07, Vol.55 (7), p.6076-6093 [Peer Reviewed Journal]Springer Science+Business Media, LLC 2017 ;Molecular Neurobiology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0893-7648 ;EISSN: 1559-1182 ;DOI: 10.1007/s12035-017-0798-6 ;PMID: 29170981Full text available |
|
15 |
Material Type: Article
|
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s DiseaseThe New England journal of medicine, 2018-01, Vol.378 (4), p.321-330 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1705971 ;PMID: 29365294Full text available |
|
16 |
Material Type: Article
|
Altered static and dynamic functional network connectivity in Alzheimer's disease and subcortical ischemic vascular disease: shared and specific brain connectivity abnormalitiesHuman brain mapping, 2019-08, Vol.40 (11), p.3203-3221 [Peer Reviewed Journal]2019 Wiley Periodicals, Inc. ;COPYRIGHT 2019 John Wiley & Sons, Inc. ;ISSN: 1065-9471 ;EISSN: 1097-0193 ;DOI: 10.1002/hbm.24591 ;PMID: 30950567Full text available |
|
17 |
Material Type: Article
|
A phase III randomized trial of gantenerumab in prodromal Alzheimer's diseaseAlzheimer's research & therapy, 2017-12, Vol.9 (1), p.95-95, Article 95 [Peer Reviewed Journal]COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s). 2017 ;ISSN: 1758-9193 ;EISSN: 1758-9193 ;DOI: 10.1186/s13195-017-0318-y ;PMID: 29221491Full text available |
|
18 |
Material Type: Article
|
High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease TauopathiesNeuron (Cambridge, Mass.), 2021-01, Vol.109 (1), p.42-58.e8 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2020.09.042 ;PMID: 33125873Full text available |
|
19 |
Material Type: Article
|
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degenerationNature medicine, 2020-03, Vol.26 (3), p.387-397 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;2020© The Author(s), under exclusive licence to Springer Nature America, Inc. 2020 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0762-2 ;PMID: 32123386Full text available |
|
20 |
Material Type: Article
|
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's diseaseNature communications, 2020-11, Vol.11 (1), p.6129-6129, Article 6129 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-19737-2 ;PMID: 33257666Full text available |